BIB ETF (ProShares Ultra Nasdaq Biotechnology) is managed by ProShares with $85.7M in net assets. BIB expense ratio is 0.95%, holding 270 positions across sectors including Other, Health Care, Unknown. Inception date: 2010-04-06.

BIB performance shows a YTD return of 4.34%. The 1-year return is 51.14% and the 5-year return is -2.50%. BIB dividend yield stands at 0.70%, paid quarterly.

BIB top holdings include Xlv Us 01/02/26 C154 (37.8%), Nasdaq Biotechnology Index Swap Citibank Na (29.6%), Nasdaq Biotechnology Index Swap Bank Of America Na (23.8%), Nasdaq Biotechnology Index Swap Goldman Sachs International (17.7%), Nasdaq Biotechnology Index Swap Societe Generale (16.6%). View all BIB holdings, sector breakdown, or dividend history.

BIB can be compared against other funds using the overlap calculator or side-by-side comparison tool. BIB alternatives are available via the screener, along with tax-loss harvesting opportunities.